Drugs Made In America Acquisition Corp. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| KARPUS MANAGEMENT, INC. | 08/14/2026 | 2.51 M | $26.71 M | -0.90% | 12.48% |
| MIZUHO SECURITIES USA LLC | 07/28/2026 | 2.07 M | $21.93 M | 3.48% | 10.30% |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 08/14/2026 | 1.15 M | $12.20 M | -28.38% | 5.70% |
| GLAZER CAPITAL, LLC | 08/17/2026 | 999.90 K | $10.65 M | -40.43% | 4.98% |
| WOLVERINE ASSET MANAGEMENT LLC | 08/10/2026 | 832.09 K | $8.86 M | -46.44% | 4.14% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 08/14/2026 | 809.05 K | $8.62 M | -38.86% | 4.03% |
| FIRST TRUST CAPITAL MANAGEMENT L.P. | 08/13/2026 | 786.46 K | $8.38 M | -64.93% | 3.91% |
| HEIGHTS CAPITAL MANAGEMENT, INC | 08/14/2026 | 648.08 K | $6.90 M | -0.29% | 3.23% |
| WESTCHESTER CAPITAL MANAGEMENT, LLC | 08/14/2026 | 581.79 K | $6.20 M | -65.14% | 2.90% |
| CLEAR STREET GROUP INC. | 08/12/2026 | 382.44 K | $1.65 M | 8.02% | 1.90% |
| ARISTEIA CAPITAL LLC | 08/14/2026 | 350.00 K | $3.73 M | -60.30% | 1.74% |
| SONA ASSET MANAGEMENT (US) LLC | 08/14/2026 | 162.80 K | $1.73 M | 0.00% | 0.81% |
| RLH CAPITAL LLC | 08/10/2026 | 115.61 K | $1.23 M | -63.48% | 0.58% |
| LOGAN STONE CAPITAL, LLC | 08/14/2026 | 109.96 K | $1.17 M | 100.00% | 0.55% |
| TORONTO DOMINION BANK | 08/14/2026 | 100.00 K | $1.07 M | -50.94% | 0.50% |
| METEORA CAPITAL, LLC | 08/14/2026 | 97.84 K | $1.04 M | -74.27% | 0.49% |
| QUARRY LP | 08/14/2026 | 65.55 K | $698.12 K | -75.41% | 0.33% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 62.27 K | $663.21 K | 0.00% | 0.31% |
| JPMORGAN CHASE & CO | 08/12/2026 | 49.89 K | $531.34 K | 0.02% | 0.25% |
| DAKOTA WEALTH MANAGEMENT | 08/07/2026 | 36.40 K | $387.66 K | 0.00% | 0.18% |
| LINEAGE POINT CAPITAL LP | 08/14/2026 | 31.84 K | $339.10 K | 0.00% | 0.16% |
| HRT FINANCIAL LP | 08/14/2026 | 18.48 K | $196.00 K | -32.76% | 0.09% |
| MORGAN STANLEY | 08/13/2026 | 28 | $298 | -51.72% | 0.00% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| AQR ARBITRAGE LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| RADCLIFFE CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| WHITEBOX ADVISORS LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| CONTEXT CAPITAL MANAGEMENT, LLC | 07/23/2026 | 0 | $0 | -100.00% | 0.00% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 09/02/2026 | 0 | $0 | -100.00% | 0.00% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| DLD ASSET MANAGEMENT, LP | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| LMR PARTNERS LLP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| WARBERG ASSET MANAGEMENT LLC | 08/11/2026 | 0 | $0 | -100.00% | 0.00% |
| GOVERNORS LANE LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| PERISCOPE CAPITAL INC. | 08/11/2026 | 0 | $0 | -100.00% | 0.00% |
| SHAOLIN CAPITAL MANAGEMENT LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| L1 GLOBAL MANAGER PTY LTD | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
Drugs Made In America Acquisition Corp. institutional Ownership - FAQ's
During the previous two years, 44 institutional investors and hedge funds held shares of Drugs Made In America Acquisition Corp.. The most heavily invested institutionals were:
Karpus Management, Inc.: 2.51 M
MIZUHO SECURITIES USA LLC: 2.07 M
Polar Asset Management Partners Inc.: 1.15 M
GLAZER CAPITAL, LLC: 999,899
WOLVERINE ASSET MANAGEMENT LLC: 832,093
HIGHBRIDGE CAPITAL MANAGEMENT LLC: 809,054
59.54% of Drugs Made In America Acquisition Corp. stock is owned by institutional investors.
Institutional investors have bought a total of 13.12 M shares in the last 24 months. This purchase volume represents approximately $137.36 M in transactions.